Yokogawa Releases SU10 Single Cellome Unit for Use in Biological Research


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Yokogawa Releases SU10 Single Cellome Unit for Use in Biological Research
For the creation of a smart cell industry

Yokogawa Electric Corporation (TOKYO: 6841) announces that it has developed the SU10 Single Cellome Unit, a device that uses a nanopipette*1 to inject substances such as genes and drugs and aspirate intracellular materials at target locations in individual cells. Targeting the biological research market, the SU10 is being released on this date in Japan, with release in other markets such as the US to follow at a later date.

Through the development of such solutions, Yokogawa’s life innovation business is fostering the development of an industry centering on the use of smart cells, i.e. finely-designed, expression-controlled biological cells.


Development Background

Rapid advances in biotechnology are leading to the development of a bioeconomy that is expected to have a wide-ranging impact on fields ranging from agriculture to manufacturing and healthcare. One segment of this bioeconomy will be the smart cell industry, which will involve the manufacture of high-performance products such as biological medicines and replacements for petroleum-derived products using finely-designed, expression-controlled cellular organisms (smart cells). Smart cells are expected to bring about major changes in the energy and environmental industries as well as such fields as agriculture, manufacturing, and healthcare, and to solve a number of problems facing humanity.


In April 2018, Yokogawa established a Life Innovation Business Headquarters with the goal of promoting well-being for all. In addition to engaging in our existing life science and manufacturing solutions businesses targeting the pharmaceutical and food industries, the headquarters will work with our customers to develop new products and services that make use of Yokogawa’s core measurement, control, and information technologies, and provide one-stop solutions that revolutionize productivity throughout the pharmaceutical and food industry value chain, from basic research to manufacturing, logistics, and services.


There is keen interest within the cancer and immunology research fields in the use of single-cell analysis to clarify the causes of diseases and study pathological conditions, and this is expected to lead to advances in drug discovery research and the development of precision medicine and regenerative medicine. With the aim of fostering the development of a smart cell industry, Yokogawa has developed the SU10 for use by researchers in single-cell analysis.

Tags : #Yokogawa #Releasessu10 #Singlecellome #Biologicalresearch

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026